MKS Instruments Inc (MKSI)vsNovanta Inc (NOVT)
MKSI
MKS Instruments Inc
$257.61
-9.71%
TECHNOLOGY · Cap: $21.93B
NOVT
Novanta Inc
$137.77
-2.72%
TECHNOLOGY · Cap: $5.11B
Smart Verdict
WallStSmart Research — data-driven comparison
MKS Instruments Inc generates 305% more annual revenue ($4.07B vs $1.00B). MKSI leads profitability with a 8.0% profit margin vs 5.3%. MKSI appears more attractively valued with a PEG of 1.32. MKSI earns a higher WallStSmart Score of 61/100 (C+).
MKSI
Buy61
out of 100
Grade: C+
NOVT
Hold44
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-71.8%
Fair Value
$150.80
Current Price
$257.61
$106.81 premium
Margin of Safety
-35.1%
Fair Value
$105.01
Current Price
$137.77
$32.76 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 53.2% YoY
15.2% revenue growth
Conservative balance sheet, low leverage
Areas to Watch
Elevated debt levels
Premium valuation, high expectations priced in
Distress zone — elevated risk
Expensive relative to growth rate
ROE of 5.2% — below average capital efficiency
5.3% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MKSI
The strongest argument for MKSI centers on EPS Growth, Revenue Growth. Revenue growth of 15.2% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bull Case : NOVT
The strongest argument for NOVT centers on Debt/Equity. Revenue growth of 10.4% demonstrates continued momentum.
Bear Case : MKSI
The primary concerns for MKSI are Debt/Equity, P/E Ratio, Altman Z-Score. A P/E of 68.1x leaves little room for execution misses. Debt-to-equity of 1.53 is elevated, increasing financial risk.
Bear Case : NOVT
The primary concerns for NOVT are PEG Ratio, Return on Equity, Profit Margin. A P/E of 102.5x leaves little room for execution misses.
Key Dynamics to Monitor
MKSI profiles as a growth stock while NOVT is a value play — different risk/reward profiles.
MKSI carries more volatility with a beta of 1.93 — expect wider price swings.
MKSI is growing revenue faster at 15.2% — sustainability is the question.
NOVT generates stronger free cash flow (46M), providing more financial flexibility.
Bottom Line
MKSI scores higher overall (61/100 vs 44/100) and 15.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MKS Instruments Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.
Visit Website →Novanta Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?